Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
90 Cards in this Set
- Front
- Back
site of B-cell localization and proliferation
|
Follicle of lymph node
|
|
differentiate primary and secondary follicles
|
primary - dense and dormant
secondary - pale central germinal centers and are active |
|
house T cells and enlarges in an extreme cellular immune response
|
paracortex
|
|
where are T cells found in the spleen
|
periarterial lymphatic sheath in the white pulp of the spleen
|
|
why are asplenic patients susceptible to encapsulated organisms
|
decreased IgM leads to decreased C3b opsonization
Salmonella, S. pneumo, H. influenzae, N. meningitidis |
|
Howell-Jolly bodies
|
postsplenectomy
either physically or with sickle cell anemia that destroys spleen |
|
does RBC express MHC I
|
No
|
|
this immune antigen is paired with B2-microglobulin which aids it for transport to cell surface
|
MHC I
|
|
this immune antigen is loaded following release of invariant chain in an acidified endosome
|
MHC II
|
|
A3
|
hemochromatosis
|
|
B27
|
psoriasis
Ankylosing spondylitis inflammatory bowel disease Reiter's syndrome |
|
B8
|
Grave's disease
|
|
DR2
|
MS
hay fever SLE Goodpasture's |
|
DR3
|
DM type 1
|
|
DR4
|
RA
DM type 1 |
|
DR5
|
pernicious anemia
Hashimoto's thyroiditis |
|
DR7
|
steroid-responsive nephrotic syndrome
|
|
only lymphocyte member of innate immune system
activity enhanced by IL-12, IFN-B, and IFN-a |
NK cell
|
|
site of positive selection in thymus
|
cortex
cell is CD4/CD8 T cell |
|
site of negative selection in thymus
|
medulla
T cell is differentiated into CD4 or CD8 |
|
Interleukins associated with inducing formation of Th1 or Th2 cell from Helper T cell
|
IL-12 --> Th1
IL-4 --> Th2 |
|
antigen presenting cells
|
macrophages
Dendritic cells B cells |
|
two signals needed for APC to activate CD4 cell
|
APC (MHC II and B7)
CD4 (TCR and CD28) |
|
two signals needed for activation of cytotoxic T cell
|
MHC I (virus-infected cell) recognized by TCR
IL-2 from Th1 |
|
two signals needed for activation of B cell class switching
|
IL-4,5,6 from Th2 cell
CD40 receptor on B cell binds CD40L on Th2 cell |
|
regulates cell-mediated response by activating macrophages and CD8 T cells (IL-2)
|
Th1 cell
|
|
regulates humoral response by activating B cell to make antibodies (IL-4 and 5)
|
Th2 cell
|
|
what inhibits Th1 cells
|
IL-10 secreted by Th2 cell
|
|
what inhibits Th2 cells
|
IFN-y secreted by Th1 cell
|
|
amino terminal of an antibody
|
antigen-binding end
|
|
carboxy terminal of an antibody
|
constant portion
|
|
complement binding part of an antibody
|
IgG and IgM antibodies can activate complement via CH2 portion of their heavy chain
|
|
which two antibodies are expressed on the surface of mature B lymphocytes
|
IgM and IgD
|
|
differentiate IgA antibody when in circulation vs. when secreted
|
monomer in circulation
dimer when secreted |
|
antibody associated as being the primary, immediate response to an antigen
|
IgM
|
|
antibody associated with hypersentivity and mediating immunity to worms by activating eosinophils
|
IgE
|
|
antigen that stimulates release of IgM antibodies only and does not result in immunologic memory
|
thymus-independent antigen:
LPS from cell envelope polysaccharide capsule |
|
what do DAF and C1 esterase inhibitor prevent
|
complement activation on self-cells
|
|
leads to hereditary angioedema
|
C1 esterase deficiency
|
|
associated with severe, recurrent pyogenic sinus and respiratory tract infections and increased susceptibility to type III hypersensitivity reaction
|
C3 deficiency
|
|
associated with Neisseria bacteremia
|
C5-8 deficiency
|
|
associated with paraxysmal nocturnal hemoglobinuria
|
DAF deficiency
|
|
defends against gram(-) bacteria
|
MAC
|
|
what activates the alternative complement system
|
endotoxin
peptidoglycan |
|
what two pathways cleave C2 and C4
|
Lectin - mannan binding
Classic - antigen-antibody complexes |
|
major chemotactic factor for neutrophils
|
IL-8
|
|
interluekin associated with fever
|
IL-1
|
|
mediates septic shock
|
TNF-a
|
|
induce the production of ribonuclease that inhibit viral protein synthesis by degrading viral mRNA
|
Interferons
|
|
stimulates growth of helper and cytotoxic T cells
|
IL-2
|
|
T cell markers
|
TCR
CD3 CD28 CD4 CD8 |
|
B cell markers
|
IgM and IgD
CD19 CD20 CD21 CD40 MHC II B7 |
|
NK cell markers
|
CD16 (binds Fc of IgG)
CD56 |
|
CD14
|
macrophage
|
|
how do endotoxins directly stimulate macrophages
|
bind to CD14
|
|
results in the uncoordinated release of IFN-y from Th1 cells and subsequent release of IL-1,6 and TNF-a from macrophages
|
superantigens (S. pyogenes and S. aureus)
|
|
immunity associated with rapid onset, but short life span of antibodies
|
passive immunity
|
|
differentiate the hypersensitivities
|
ACID:
Anaphylactic (type I) Cytotoxic (antibody mediated) (type II) immune complex (type III) Delayed T-cell mediated (type IV) |
|
anti-dsDNA
anti-Smith |
SLE
|
|
antihistone
|
drug-induced lupus
|
|
anti-IgG
|
rheumatoid arthritis
|
|
anticentromere
|
scleroderma (CREST)
|
|
anti-Scl-70 (anti-DNA topoisomerase I)
|
scleroderma (diffuse)
|
|
antimitochondrial
|
primary biliary cirrhosis
|
|
antigliadin
antiendomysial |
celiac disease
|
|
anti-basement membrane
|
goodpasture's syndrome
|
|
anti-desmoglein
|
pemphigus vulgaris
|
|
anti-Jo-1
|
polymyositis
dermatomyositis |
|
anti-SS-A/B
|
Sjogren's syndrome
|
|
Anti-U1 RNP (ribonucleoprotein)
|
mixed connective tissue disease
|
|
c-ANCA
|
Wegener's granulomatosis
|
|
anti-glutamate decarboxylase
|
type 1 DM
|
|
X-linked recessive defect in BTK, a tyrosin kinase gene that blocks B-cell differentiation
|
Bruton's agammaglobinemia
|
|
defective CD40L on helper T cells - inability to class switch
|
hyper-IgM syndrome
|
|
when does children with Bruton's get infections
|
after 6 months - when maternal IgG decreases
|
|
associated with sinus and lung infection and anaphylaxis on exposure to blood products
|
IgA deficiency
blood products that contain IgA produce anaphylaxis |
|
associated with a defect in B-cell maturation, normal number of B cells but decreased plasma cells and immunoglobin
|
common variable immunodeficiency
|
|
22q11 deletion associated with tetany and congenital heart and great vessel defects
|
Thymic aplasia (DiGeorge syndrome)
|
|
Decreased Th1 response and IFN-y
|
IL-12 receptor deficiency
|
|
Hyper-IgE syndrome (Job's syndrome)
|
FATED:
coarse Facies staph Abscesses retained primary Teeth increased IgE Dermatologic problems (eczema) |
|
two types of SCID
|
x-linked defect in IL-2 receptor -decreased T cell activation
adenosine deaminase deficiency - increased adenine which is toxic to B and T cells |
|
ataxia, spider angiomas, and IgA deficiency
Cause |
Ataxia-telangietasia
Defect in DNA repear |
|
x-linked recessive defect with progressive deletion of B and T cells associated with:
thrombocytopenic purpura Infections Eczema decreased IgM |
Wiskott-Aldrich syndrome
|
|
defect in LFA-1 integrin (CD18) on phagocytes
|
Leukocyte Adhesion deficiency (type-1)
|
|
autosomal recessive defect in microtubular function with decreased phagocytosis
|
Chediak-Higashi syndrome
|
|
lack of NADPH oxidase resulting in decreased superoxide and absent respiratory burst in neutrophils
|
Chronic granulomatous disease
|
|
increased susceptibility to catalase-positive organisms with a negative nitroblue tetrazolium dye reduction test
|
chronic granulomatous disease
|
|
hyperacute rejection
|
type II hypersensitivity due to presence of preformed antidonor antibodies that occludes graft vessels causing ischemia and necrosis
|
|
graft-versus-host disease
|
immunocompetent T cell from the graft attack the immnocompromised host resulting in severe organ dysfunction (usually bone marrow and liver transplant)
|
|
T-cell and antibody-mediated vascular damage in transplant rejection
|
chronic rejection (months to years later)
|